Infrared Sauna Research

This comprehensive review by Laukkanen and Kunutsor synthesizes the evidence on passive heat therapies including Finnish sauna, infrared sauna, and hot water immersion for extending healthspan.

Key findings:

• Frequent sauna bathing (4-7x/week) is associated with significant reductions in cardiovascular mortality, sudden cardiac death, and all-cause mortality
• Dose-response relationship: longer session duration and higher frequency correlate with greater risk reduction
• Heat therapy improves cardiovascular function, endothelial health, and autonomic nervous system balance
• Associated with reduced risk of dementia, Alzheimer disease, and respiratory conditions
• Anti-inflammatory and hormetic stress response pathways mediate many benefits

Mechanisms:

• Activation of heat shock proteins (HSP70, HSP90)
• Improved nitric oxide bioavailability and vascular function
• Reduced systemic inflammation (CRP, IL-6)
• Enhanced autonomic regulation and heart rate variability
• Positive effects on lipid profiles and blood pressure

Clinical significance:

Provides strong epidemiological and mechanistic evidence that regular passive heat therapy is a practical, accessible intervention for reducing chronic disease risk and extending healthspan, with benefits comparable to moderate physical exercise.

This systematic review examined the evidence for infrared radiation therapy in managing musculoskeletal conditions and chronic pain.

Key findings:

• Infrared therapy demonstrated significant pain reduction across multiple musculoskeletal conditions including chronic low back pain, knee osteoarthritis, and fibromyalgia
• Far-infrared radiation was effective for both acute and chronic pain management
• Treatment improved functional outcomes and quality of life in several patient populations
• The therapy showed a favorable safety profile with minimal adverse effects

Conditions reviewed:

• Chronic low back pain
• Knee osteoarthritis
• Fibromyalgia
• Temporomandibular disorders
• Ankylosing spondylitis

Clinical significance:

Provides a consolidated evidence base supporting infrared radiation as a non-pharmacological adjunct for chronic pain management, though the authors note that more high-quality RCTs are needed to establish optimal protocols and treatment parameters.

This study evaluated a far-infrared low-temperature sauna program for reducing geriatric syndrome and frailty in community-dwelling older adults.

Key findings:

• Far-infrared sauna sessions improved physical performance and reduced fatigue in elderly participants
• Frailty markers including grip strength and walking speed showed improvement after the intervention
• The low-temperature protocol (around 60C) was well-tolerated by the geriatric population
• Participants reported improvements in sleep quality and overall well-being

Protocol:

• Far-infrared sauna at low temperatures (~60C)
• Regular sessions over the study period
• Community-dwelling older adults as participants

Clinical significance:

Demonstrates that far-infrared sauna therapy at moderate temperatures is a safe and effective intervention for older adults, addressing multiple components of frailty simultaneously. The low-temperature approach makes this accessible to populations who cannot tolerate traditional high-heat saunas.

This systematic review and meta-analysis by Kallstrom et al. (2019) investigated whether sauna bathing could benefit patients with heart failure. The authors searched PubMed, Cochrane Library, and CINAHL databases, screening 1,444 studies and identifying 9 controlled studies that met inclusion criteria, of which 7 were included in the meta-analysis.

All qualifying studies used infrared sauna (specifically far-infrared at approximately 60 degrees C for 15 minutes, followed by 30 minutes of rest with blanket wrapping, performed five times weekly for 2-4 weeks). This protocol is consistent with the Japanese Waon therapy approach. The meta-analysis found significant improvements in B-type natriuretic peptide (a biomarker for heart failure severity), left ventricular ejection fraction, and cardiothoracic ratio.

However, no significant effects were found for blood pressure or certain heart chamber measurements. The authors noted that evidence strength varied from moderate to insufficient and emphasized the need for more research on long-term effects and the potential benefits of Finnish-style sauna for cardiovascular health.

This comprehensive review by Crinnion (2011) examines the clinical evidence for sauna therapy across multiple health conditions. The paper draws on the historical use of sauna in Scandinavian culture and reviews modern research on both traditional and far-infrared sauna applications.

The review documents evidence supporting sauna therapy for a range of conditions including hypertension, congestive heart failure, post-myocardial infarction recovery, chronic obstructive pulmonary disease (COPD), chronic fatigue, chronic pain, and addiction treatment. Both radiant heat and far-infrared sauna units are covered.

A notable section addresses sauna-based detoxification protocols for environmentally-induced illness. The author reviews studies using radiant heating units as part of depuration (purification) protocols, examining the evidence for mobilization and excretion of stored toxicants through sweat. The review concludes that regular sauna therapy appears safe for most users, with pregnancy being a notable concern due to hyperthermia risks.

The paper provides a broad clinical overview that positions sauna therapy as a legitimate therapeutic tool rather than just a wellness practice, covering cardiovascular, autoimmune, and toxicant-related conditions with supporting evidence.

This review by Beever (2009) systematically examined the published evidence on far-infrared sauna (FIRS) therapy for cardiovascular risk factors and other health conditions. The author searched multiple databases including Web of Science, EBSCO, Ovid MEDLINE, Ovid HealthSTAR, and EMBASE to identify relevant human studies published in English.

The search yielded nine relevant papers meeting Level I or II evidence criteria. Four papers supported FIRS use for congestive heart failure, while five papers addressed various coronary risk factors. The evidence was categorized by strength: limited moderate evidence for blood pressure normalization and heart failure treatment, fair evidence from a single study for chronic pain management, and weak evidence from single studies for chronic fatigue syndrome and obesity.

Notably, the review found strong evidence contradicting manufacturer claims that FIRS therapy could reduce cholesterol levels. The author concluded that while FIRS shows promise for certain cardiovascular conditions, the overall evidence base remains limited and more rigorous research is needed.